Quintrio
Home

IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Neogen Corp

NEOG

Neogen Corp is develop, manufacture and market a diverse line of products and services dedicated to food and animal safety. Its Food Safety segment consists mainly of diagnostic test kits and complementary products (e.g., culture media) sold to food and animal feed producers and processors to preserve the safety and quality of food to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. These products also ensure the general hygiene of the food manufacturing environment. It also have products to determine food quality and nutritional components. Its segments are Food, Animal safety. Majority of revenue comes from Food Safety. It has presence in United states, and International market.

Last trade $10.94
Day change +$0.055 (+0.51%)
Day range $10.75 – $11.20
Volume 750,381
Market cap $2.38B

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$2.38B
Price / earnings
—
Price / book
1.14×
Price / sales
2.69×
EV / sales
3.37×
EV / EBITDA
27.35×

Profitability

Earnings per share
-$0.26
Return on assets
-1.7%
Return on equity
-2.69%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0.37×
Current ratio
4.1×
Quick ratio
3.07×
Cash ratio
1.21×

Cash flow

Price / cash flow
27.86×
Price / free cash flow
47.74×
Free cash flow
$49.75M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for NEOG, quarterly periods
Line itemQ1 FY2027 Aug 31, 2026Q4 FY2026 May 31, 2026Q3 FY2026 Feb 28, 2026Q2 FY2026 Nov 30, 2025Q1 FY2026 Aug 31, 2025Q4 FY2025 May 31, 2025Q3 FY2025 Feb 28, 2025Q2 FY2025 Nov 30, 2024
Revenue$222.8M$225.3M$211.2M$224.69M$209.2M$225.5M$221M$231.26M
Cost of revenue$117.3M$117.5M$112.2M$118.01M$114.2M$132.6M$110.7M$117.93M
Gross profit$105.5M$107.8M$99M$106.68M$95M$92.9M$110.3M$113.33M
Selling, general and administrative$100.8M$99.8M$98.5M$107.5M$106M$99.9M$100.4M$104.32M
Research and development$6.5M$4.9M$3.8M$4.56M$5.1M$6.3M$4.5M$5.11M
Total operating expenses$107.3M$104.7M$102.3M$112.06M$111.1M$704.1M$104.9M$570.81M
Operating income-$1.8M$3.1M-$3.3M-$5.38M-$16.1M-$611.2M$5.4M-$457.48M
Interest expense-$13.8M-$13.9M-$13.9M-$14.85M-$15.5M-$16.5M-$17M-$18.14M
Income before taxes-$14.9M-$12.1M-$20.3M-$20.36M$43.8M-$631.2M-$9.7M-$476.57M
Income taxes-$3M-$800K-$3.3M-$4.44M$7.5M-$19M$1.2M-$20.29M
Net income-$11.9M-$11.3M-$17M-$15.92M$36.3M-$612.2M-$10.9M-$456.28M
Net income attributable to common shareholders-$11.9M-$11.3M-$17M-$15.92M$36.3M-$612.2M-$10.9M-$456.28M
EBITDA$27.3M$32.5M$25.62M$23.55M$13M$17M$34.75M$33.96M
Basic earnings per share-$0.05-$0.05-$0.08-$0.07$0.17-$2.82-$0.05-$2.10
Diluted earnings per share-$0.05-$0.05-$0.08-$0.07$0.17-$2.82-$0.05-$2.10

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

Neogen (NEOG) Up 6.7% Since Last Earnings Report: Can It Continue?

Neogen (NEOG) reported strong Q1 fiscal 2027 results with earnings and revenue beating consensus estimates and raised full-year guidance. However, analyst estimates have shifted downward by 33.33% in the past month. The stock carries a Zacks Rank #3 (Hold) with a C aggregate VGM Score, suggesting in-line returns ahead despite recent 6.7% outperformance versus the S&P 500.

GlobeNewswire Inc.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG

The FDA issued a warning letter to Neogen Corporation on September 29, 2026, following an investigation linking its veterinary wound care product Neogen Vet HYCOAT to at least 20 horse deaths due to contamination. The incident represents the largest number of horse deaths associated with a quality defect in an FDA-regulated veterinary product. Neogen initiated a voluntary recall in January 2026. The announcement triggered a 7.22% stock price decline. Pomerantz LLP is investigating potential securities fraud claims on behalf of investors.

GlobeNewswire Inc.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG

Pomerantz LLP is investigating potential securities fraud claims against Neogen Corporation following an FDA warning letter regarding its veterinary wound care product HYCOAT, which was linked to at least 20 horse deaths—the largest number of deaths associated with a quality defect in an FDA-regulated veterinary product. Neogen initiated a voluntary recall in January 2026, and the stock fell 7.22% on the news.

GlobeNewswire Inc.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Rafael Holdings, Inc. - RFL

Pomerantz LLP is investigating securities fraud claims on behalf of investors of Rafael Holdings, Inc. after the company announced that its Phase 3 clinical trial for Trappsol Cyclo failed to achieve statistical significance on its primary endpoint. Rafael's stock price fell 34.98% following the announcement on September 30, 2026. The law firm is also investigating similar claims against FMC Corporation and Neogen Corporation.

Zacks Investment Research

NEOG vs. WFCF: Which Food Safety Stock Has Better Prospects?

Neogen Corporation (NEOG) and Where Food Comes From, Inc. (WFCF) are compared as investment opportunities in the food safety and agricultural verification sectors. NEOG demonstrates stronger growth momentum with 6.5% revenue growth, improving margins, and strategic initiatives like Petrifilm manufacturing transition and Genomics divestiture to reduce debt. WFCF offers a more conservative balance sheet with improving profitability but faces challenges from slow revenue growth and heavy exposure to the struggling U.S. cattle industry. NEOG is positioned better for growth-focused investors despite higher debt, while WFCF appeals to conservative investors seeking stability.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Jun 7, 20212-for-1forward split
Jan 2, 20184-for-3forward split
Oct 31, 20133-for-2forward split
Dec 16, 20093-for-2forward split
Sep 5, 20073-for-2forward split
Jan 2, 20045-for-4forward split